By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OVATION Pharmaceuticals
(Acquired by Lundbeck in March 2009)
 

Press releases archived for reference only.
See Lundbeck profile.
Four Parkway North, Suite 200
Deerfield
  Illinois  60015  U.S.A.
Phone: 800-455-1141 Fax: 847-282-1001


SEARCH JOBS








Company News
Innovus Pharma Announces Start Of Its Circumserum™ Commercial Phase In Morocco With Initial Order Of 10,000 Units By Its Partner OVATION Pharmaceuticals (Acquired by Lundbeck in March 2009) 12/27/2013 7:12:53 AM
Innovus Pharma Signs Second License and Distribution Agreement With OVATION Pharmaceuticals (Acquired by Lundbeck in March 2009) for EjectDelay™ in Morocco 9/11/2013 9:23:20 AM
Innovus Pharma Signs License and Distribution Agreement With OVATION Pharmaceuticals (Acquired by Lundbeck in March 2009) for CIRCUMserum™ in Morocco 9/9/2013 9:33:26 AM
H. Lundbeck A/S' Acquisition of Ovation Pharmaceuticals Cleared by US Federal Trade Commission 3/19/2009 1:28:38 PM
GTCR Completes the Sale of Ovation Pharmaceuticals to Lundbeck Inc. (formerly Ovation Pharmaceuticals) 3/19/2009 8:46:06 AM
GTC Biotherapeutics (GTCB) Reports Progress in ATryn Program in U.S. 3/9/2009 8:30:02 AM
OVATION Pharmaceuticals, Inc. Receives Frost & Sullivan’s 2009 Entrepreneurial Company of the Year Award 2/26/2009 10:16:15 AM
OVATION Pharmaceuticals, Inc. Proudly Supports National Rare Disease Day 2/25/2009 10:16:54 AM
GTC Biotherapeutics (GTCB) And OVATION Pharmaceuticals, Inc.'s ATryn(R) (Antithrombin [Recombinant]) Approved by the FDA 2/6/2009 10:44:18 AM
S&R Communications Group Partners With OVATION Pharmaceuticals, Inc. to Launch Xenazine (tetrabenazine) 1/14/2009 7:09:13 AM
1234
//-->